Literature DB >> 22729654

Renoprotective effects of renin-angiotensin-aldosterone system blockers in type 2 diabetes: demystifying multiple treatment comparisons in a network meta-analysis.

F Catalá-López.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22729654     DOI： 10.1007/s00125-012-2619-9

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  4 in total

1.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

Authors:  E J Lewis; L G Hunsicker; W R Clarke; T Berl; M A Pohl; J B Lewis; E Ritz; R C Atkins; R Rohde; I Raz
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

Review 2.  Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses.

Authors:  John P A Ioannidis
Journal:  CMAJ       Date:  2009-08-04       Impact factor: 8.262

Review 3.  Reno-protective effects of renin-angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis.

Authors:  P Vejakama; A Thakkinstian; D Lertrattananon; A Ingsathit; C Ngarmukos; J Attia
Journal:  Diabetologia       Date:  2011-12-22       Impact factor: 10.122

4.  Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study.

Authors:  E Imai; J C N Chan; S Ito; T Yamasaki; F Kobayashi; M Haneda; H Makino
Journal:  Diabetologia       Date:  2011-10-13       Impact factor: 10.122
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.